These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10803579)

  • 1. Androgen-induced growth inhibition of androgen receptor expressing androgen-independent prostate cancer cells is mediated by increased levels of neutral endopeptidase.
    Shen R; Sumitomo M; Dai J; Harris A; Kaminetzky D; Gao M; Burnstein KL; Nanus DM
    Endocrinology; 2000 May; 141(5):1699-704. PubMed ID: 10803579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
    Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells.
    Dai J; Shen R; Sumitomo M; Goldberg JS; Geng Y; Navarro D; Xu S; Koutcher JA; Garzotto M; Powell CT; Nanus DM
    Clin Cancer Res; 2001 May; 7(5):1370-7. PubMed ID: 11350908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY; Ly LH; Peehl DM; Feldman D
    Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
    Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
    Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
    Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM
    Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.
    Papandreou CN; Usmani B; Geng Y; Bogenrieder T; Freeman R; Wilk S; Finstad CL; Reuter VE; Powell CT; Scheinberg D; Magill C; Scher HI; Albino AP; Nanus DM
    Nat Med; 1998 Jan; 4(1):50-7. PubMed ID: 9427606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
    Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
    Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of the neutral endopeptidase gene promoter in human prostate cancers.
    Usmani BA; Shen R; Janeczko M; Papandreou CN; Lee WH; Nelson WG; Nelson JB; Nanus DM
    Clin Cancer Res; 2000 May; 6(5):1664-70. PubMed ID: 10815884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway.
    Sumitomo M; Milowsky MI; Shen R; Navarro D; Dai J; Asano T; Hayakawa M; Nanus DM
    Cancer Res; 2001 Apr; 61(8):3294-8. PubMed ID: 11309283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
    van der Poel HG
    Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
    Lee C; Sutkowski DM; Sensibar JA; Zelner D; Kim I; Amsel I; Shaw N; Prins GS; Kozlowski JM
    Endocrinology; 1995 Feb; 136(2):796-803. PubMed ID: 7530653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C; Hum DW; Bélanger A
    Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function.
    Adam RM; Kim J; Lin J; Orsola A; Zhuang L; Rice DC; Freeman MR
    Endocrinology; 2002 Dec; 143(12):4599-608. PubMed ID: 12446587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha represses androgen sensitivity in the LNCaP prostate cancer cell line.
    Mizokami A; Gotoh A; Yamada H; Keller ET; Matsumoto T
    J Urol; 2000 Sep; 164(3 Pt 1):800-5. PubMed ID: 10953159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.